Related Experiment Video

Updated: Nov 8, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.6K

Long-term survival of two patients with recurrent high-risk neuroblastoma

Tomonobu Sato1, Kazuya Hara2, Go Ohba3

  • 1Department of Pediatrics, Kitami Red Cross Hospital, Kitami, Japan.

Pediatrics International : Official Journal of the Japan Pediatric Society
|April 27, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
aggressive surgical interventionhigh-risk neuroblastoma (HR-NB)recurrent neuroblastomarefractory neuroblastoma

More Related Videos

Surgical Treatment of an Endolymphatic Sac Tumor04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

1.1K
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

514

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K